ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699926 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699926; 2) Community: the network communities that were significantly associated with the response to NSC 699926; 3) Molecule: the relationships between components within communities and NSC 699926; 4) MDR: the compounds that were significantly associated with the NSC 699926.

NSC Compound Enrichment Correlation
NSC 746691 (2E)-2-Benzoyl-3-(2-phenyl-1H-indol-3-yl)acrylonitrile 0.00454081715455577 0.19933276
NSC 131233 Cyclopentanone, 2,5-bis[(dimethylamino)methyl]-, dihydrochloride 0.00544455191490919 0.52995898
NSC 749161 Null 0.00577660600506179 0.17733195
NSC 47786 9H-Purin-2-amine, 6-[[(2,4-dichlorophenyl)methyl]thio]-9-(2-methylpropyl)- 0.00628187335688596 -0.025932479
NSC 29443 Null 0.00628187335688605 0.45759397
NSC 295500 Camptothecin Derivative 0.00628187335688605 -0.076346524
NSC 69577 Null 0.00628187335688605 0.66337317
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.00628187335688605 0.63334771
NSC 669517 Null 0.00701295499506013 0.71629181
NSC 678106 Rhamnazin 0.00701295499506013 -0.11713048
Total:40  Current:6    [First] [Prev] [Next] [Last]